微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 3.25% | 7.97% | 103.13% | 45/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 1.6% | -1.84% | -77.84% | 54/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 7.22% | -1.77% | 16.45% | 40/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 6.2% | -2.82% | 105.98% | 42/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 3.01% | -35.96% | 84.66% | 56/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 1.63% | -40.07% | -77.82% | 53/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 7.35% | 18.36% | 15.2% | 47/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 6.38% | 38.1% | 35.74% | 47/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 4.7% | 57.72% | 72.79% | 43/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 2.72% | 223.81% | -56.2% | 36/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 6.21% | -1.27% | 34.42% | 66/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 4.62% | 18.77% | 55.03% | 69/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 2.98% | 38.6% | 254.76% | 70/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 0.84% | 47.37% | -86.65% | 91/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 6.29% | -1.87% | 61.7% | 89/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 3.89% | -7.6% | 80.93% | 94/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 2.15% | -22.94% | 277.19% | 96/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 0.57% | -38.04% | -91.11% | 97/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 6.41% | 26.93% | 52.26% | 104/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 4.21% | 81.47% | 50.9% | 95/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 2.79% | 93.75% | 203.26% | 102/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 0.92% | 15% | -81.78% | 91/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 5.05% | 113.98% | 117.67% | 108/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 2.32% | 29.61% | 61.11% | 78/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 1.44% | -26.9% | 80% | 98/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 0.8% | 60% | -66.1% | 60/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 2.36% | -10.61% | 31.84% | 103/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 1.79% | -53.51% | -9.14% | 61/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 1.97% | -40.84% | 294% | 63/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 0.5% | -25.37% | -81.06% | 51/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 2.64% | -46.34% | -31.43% | 93/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 3.85% | 15.96% | 15.62% | 47/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 3.33% | 20.22% | 397.01% | 40/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 0.67% | 15.52% | -86.38% | 47/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 4.92% | -42.59% | 48.19% | 84/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 3.32% | -15.09% | 19.86% | 43/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 2.77% | -12.06% | 377.59% | 45/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 0.58% | -3.33% | -93.23% | 42/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 8.57% | 0.35% | 119.18% | 58/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 3.91% | -16.81% | 24.13% | 33/141 | 8.86% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 3.15% | -18.6% | 425% | 37/141 | 6.35% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 0.6% | -36.17% | -92.97% | 30/141 | 2.3% | 健帆生物 | 7.75% | 行业排名> |